LEUCINE-RICH REPEAT CONTAINING 10 (LRRC10) AND DILATED CARDIOMYOPATHY

Leucine-rich repeat containing protein 10 (LRRC10) is a cardiomyocyte-specific member of the Leucine-rich repeat containing (LRRC) protein superfamily with critical roles in cardiac function and disease pathogenesis. Recent studies have identified LRRC10 mutations in human idiopathic dilated cardio...

Full description

Bibliographic Details
Main Authors: Matthew J Brody, Youngsook Lee
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-08-01
Series:Frontiers in Physiology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fphys.2016.00337/full
_version_ 1818854435365847040
author Matthew J Brody
Youngsook Lee
author_facet Matthew J Brody
Youngsook Lee
author_sort Matthew J Brody
collection DOAJ
description Leucine-rich repeat containing protein 10 (LRRC10) is a cardiomyocyte-specific member of the Leucine-rich repeat containing (LRRC) protein superfamily with critical roles in cardiac function and disease pathogenesis. Recent studies have identified LRRC10 mutations in human idiopathic dilated cardiomyopathy (DCM) and Lrrc10 homozygous knockout mice develop DCM, strongly linking LRRC10 to the molecular etiology of DCM. LRRC10 localizes to the dyad region in cardiomyocytes where it can interact with actin and α-actinin at the Z-disc and associate with T-tubule components. Indeed, this region is becoming increasingly recognized as a signaling center in cardiomyocytes, not only for calcium cycling, excitation-contraction coupling, and calcium-sensitive hypertrophic signaling, but also as a nodal signaling hub where the myocyte can sense and respond to mechanical stress. Disruption of a wide range of critical structural and signaling molecules in cardiomyocytes confers susceptibility to cardiomyopathies in addition to the more classically studied mutations in sarcomeric proteins. However, the molecular mechanisms underlying DCM remain unclear. Here, we review what is known about the cardiomyocyte functions of LRRC10, lessons learned about LRRC10 and DCM from the Lrrc10 knockout mouse model, and discuss ongoing efforts to elucidate molecular mechanisms whereby mutation or absence of LRRC10 mediates cardiac disease.
first_indexed 2024-12-19T07:52:40Z
format Article
id doaj.art-39391f20163345d79a6473457fbcec58
institution Directory Open Access Journal
issn 1664-042X
language English
last_indexed 2024-12-19T07:52:40Z
publishDate 2016-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Physiology
spelling doaj.art-39391f20163345d79a6473457fbcec582022-12-21T20:30:05ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2016-08-01710.3389/fphys.2016.00337213581LEUCINE-RICH REPEAT CONTAINING 10 (LRRC10) AND DILATED CARDIOMYOPATHYMatthew J Brody0Youngsook Lee1Cincinnati Children's Hospital Medical CenterUniversity of Wisconsin-MadisonLeucine-rich repeat containing protein 10 (LRRC10) is a cardiomyocyte-specific member of the Leucine-rich repeat containing (LRRC) protein superfamily with critical roles in cardiac function and disease pathogenesis. Recent studies have identified LRRC10 mutations in human idiopathic dilated cardiomyopathy (DCM) and Lrrc10 homozygous knockout mice develop DCM, strongly linking LRRC10 to the molecular etiology of DCM. LRRC10 localizes to the dyad region in cardiomyocytes where it can interact with actin and α-actinin at the Z-disc and associate with T-tubule components. Indeed, this region is becoming increasingly recognized as a signaling center in cardiomyocytes, not only for calcium cycling, excitation-contraction coupling, and calcium-sensitive hypertrophic signaling, but also as a nodal signaling hub where the myocyte can sense and respond to mechanical stress. Disruption of a wide range of critical structural and signaling molecules in cardiomyocytes confers susceptibility to cardiomyopathies in addition to the more classically studied mutations in sarcomeric proteins. However, the molecular mechanisms underlying DCM remain unclear. Here, we review what is known about the cardiomyocyte functions of LRRC10, lessons learned about LRRC10 and DCM from the Lrrc10 knockout mouse model, and discuss ongoing efforts to elucidate molecular mechanisms whereby mutation or absence of LRRC10 mediates cardiac disease.http://journal.frontiersin.org/Journal/10.3389/fphys.2016.00337/fullcardiomyopathydilated cardiomyopathyLeucine-Rich RepeatEccentric hypertrophyLrrc10
spellingShingle Matthew J Brody
Youngsook Lee
LEUCINE-RICH REPEAT CONTAINING 10 (LRRC10) AND DILATED CARDIOMYOPATHY
Frontiers in Physiology
cardiomyopathy
dilated cardiomyopathy
Leucine-Rich Repeat
Eccentric hypertrophy
Lrrc10
title LEUCINE-RICH REPEAT CONTAINING 10 (LRRC10) AND DILATED CARDIOMYOPATHY
title_full LEUCINE-RICH REPEAT CONTAINING 10 (LRRC10) AND DILATED CARDIOMYOPATHY
title_fullStr LEUCINE-RICH REPEAT CONTAINING 10 (LRRC10) AND DILATED CARDIOMYOPATHY
title_full_unstemmed LEUCINE-RICH REPEAT CONTAINING 10 (LRRC10) AND DILATED CARDIOMYOPATHY
title_short LEUCINE-RICH REPEAT CONTAINING 10 (LRRC10) AND DILATED CARDIOMYOPATHY
title_sort leucine rich repeat containing 10 lrrc10 and dilated cardiomyopathy
topic cardiomyopathy
dilated cardiomyopathy
Leucine-Rich Repeat
Eccentric hypertrophy
Lrrc10
url http://journal.frontiersin.org/Journal/10.3389/fphys.2016.00337/full
work_keys_str_mv AT matthewjbrody leucinerichrepeatcontaining10lrrc10anddilatedcardiomyopathy
AT youngsooklee leucinerichrepeatcontaining10lrrc10anddilatedcardiomyopathy